Alignment Healthcare, Inc. Stock Price, News & Analysis

Alignment Healthcare (NASDAQ: ALHC) announced that CEO John Kao will participate in the inaugural Forbes Health in Action summit on June 8, 2021. The virtual event focuses on healthcare shifts post-pandemic and will explore disparities exacerbated by COVID-19. Kao will address 'Reaching Vulnerable Populations in the Pandemic,' discussing gaps in healthcare for seniors. Other speakers include Moderna’s CEO Stéphane Bancel. Alignment Healthcare aims to provide customized Medicare Advantage plans for seniors and those in need.

Alignment Healthcare has introduced the Harmony (HMO) Plan, celebrating AAPI Heritage Month. This Medicare Advantage plan allows members access to traditional Eastern medicine like acupuncture and chiropractic services without additional costs. Over 1,800 members have already enrolled within its first year. The plan is designed for diverse senior communities in Santa Clara and San Diego counties, featuring zero monthly premiums, 19 acupuncture visits, and a $30 monthly allowance for over-the-counter items. The plan also includes virtual care access and additional health services.

Alignment Healthcare's Care Anywhere program, launched in 2017, serves over 4,000 high-risk Medicare Advantage members, achieving a Net Promoter Score of 76, significantly higher than the industry average of 30-40. The program reduces care costs through coordinated virtual care tailored to seniors with chronic conditions. Following the COVID-19 pandemic, all patient interactions shifted to virtual platforms. Care Anywhere has successfully lowered hospitalization and emergency visit rates compared to standard Medicare performance, significantly impacting claims expenditures for at-risk members.

On May 24, 2021, Alignment Healthcare (Nasdaq: ALHC) announced participation in the 41st Annual William Blair Growth Stock Conference. CEO John Kao and CFO Thomas Freeman will engage in a fireside chat on June 3, 2021, at 1:40 p.m. ET. The event can be accessed via webcast, with links available on the company’s investor relations page.

Alignment Healthcare is a tech-enabled Medicare Advantage company focused on delivering personalized health care to seniors and chronically ill patients. They provide customized care through various health plan options aimed at improving benefits and lowering costs.

Alignment Healthcare reported strong first-quarter results for 2021, with health plan membership growing 32% year-over-year to approximately 83,100. Total revenue reached $267.1 million, a 19% increase, primarily driven by a 30% rise in health plan premium revenue, totaling $264.7 million. Adjusted gross profit stood at $22.6 million, while adjusted EBITDA was $(14.0) million. Looking ahead, the company forecasts membership between 83,300 and 83,700 and expects revenue of $265 to $270 million for the second quarter. Total cash as of March 31, 2021, was $528.4 million.

Alignment Healthcare (ALHC) will report its Q1 2021 financial results on May 17, 2021, post-market. The company focuses on Medicare Advantage, offering technology-enabled, customized health care for seniors and chronically ill patients. The results will be discussed in a conference call at 5 p.m. E.T., accessible to both U.S. and international participants. The conference will also be available as a replay for on-demand listening for up to 12 months at their investor relations website.

Alignment Healthcare announced the closing of its initial public offering on March 30, 2021, of 27,200,000 shares of common stock at $18.00 per share, raising approximately $390.6 million in gross proceeds. The offering included 5,500,000 shares sold by existing stockholders. The funds will be utilized for working capital, general corporate purposes, and to strengthen the balance sheet. Joint book-running managers include Goldman Sachs, Morgan Stanley, and J.P. Morgan. The stock is listed on Nasdaq under the symbol ALHC.

Alignment Healthcare announced the pricing of its initial public offering (IPO) of 27,200,000 shares at $18.00 per share, including 5,500,000 shares from existing stockholders. Underwriters have a 30-day option to purchase an additional 4,080,000 shares. Trading is set to begin on the Nasdaq under the symbol ALHC on March 26, 2021, with the offering closing on March 30, 2021. Proceeds will be used for working capital, corporate growth investments, and debt repayment.